Diabetic Macular Edema Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Diabetic Macular Edema Treatment Market: By Indication Type (Diffuse Diabetic Macular Edema, Focal Diabetic Macular Edema), By Treatment (Laser treatment, Intravitreal Steriods, Anti-angiogenic Drugs Injection, Anti–vascular Endothelial Growth Factor (VEGF) Therapy, Others), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers), and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific).

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Diabetic Macular Edema Treatment Market is projected to grow at a CAGR of 3.5% during the forecast period 2021 to 2027. Diabetic macular edema is a leading cause of vision impairment among people. Macular edema occurs when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling leading to distorted vision. Diabetic macular edema is a disease that is followed by diabetic retinopathy. Diabetic retinopathy is the condition which severely damages the blood vessels of the retina, resulting in vision defects or vision loss. These blood vessels, if left untreated, due to pressure in the eye results in fluid leakage, causing Diabetic Macular Edema (DME). Increase in the prevalence of diabetes is the major factor driving growth of global market. The prevalence of diabetic macular edema is found to be higher in type 2 diabetes patients than in type 1 diabetes patients. In the projected period of 2020-2027, new and creative research and development for the treatment of diabetic macular edoema would likely increase the growth of the diabetic macular edema treatment market. On the other hand, advancements in ophthalmic surgery techniques and pharmaceutical firms’ R&D investments would enhance numerous opportunities, resulting in the diabetic macular edoema treatment market growing over the projection period. During the projected period, the diabetic macular edoema treatment market is expected to be hampered by high medical costs for patients and frequent visits to physicians. There is no need for treatment in the early stages of DME unless the patients are able to keep their blood sugar levels under control. Laser photocoagulation is the standard treatment for diabetic macular edoema if the condition becomes severe. This method involves administering a pattern of burns or cauterising leaky blood vessels using a laser to minimise edoema. Retinal experts use anti-vascular endothelial growth factorcorticosteroids injections in combination with laser photocoagulation to avoid the treatment’s negative effects. Only two approved medications for treating DME are now available on the market: Lucentis and Ozurdex. Clinical trials are now underway for other therapy options.

Diabetic Macular Edema Treatment Market

MARKET SUMMARY
-
3.5% CAGR
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 3.5%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– Europe

Diabetic Macular Edema Treatment Market

  • The report on global Diabetic Macular Edema Treatment Market gives historical, current, and future market sizes (US$ Mn) on the basis of indication type, treatment, end user and geography.
  • Diabetic Macular Edema Treatment Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Eyetech Pharmaceuticals (U.S)
  • Alimera Sciences (U.S)
  • Archemix (U.S)
  • Genentech Inc. (U.S)
  • Novartis Europharm Limited (Novartis AG) (India)
Dynamics

Diabetic Macular Edema Treatment Market

The increased geriatric population and awareness among the patient pool which facilitates early diagnosis to control the disease by proper treatment is driving the market revenue growth. Moreover, advancement in ophthalmic surgery techniques and R&D investment by pharmaceutical companies are adding fuel to the growth of the market. However, factors such as lack of skilled ophthalmologists, and extended approval time for drugs are hampering the market.


Asia-Pacific got significant share

Diabetic Macular Edema Treatment Market

Geographically, global diabetic macular edema treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia-Pacificdiabetic macular edema treatment market growth is driven by increases in the prevalence of diabetes. Availability large patient pool in Asia-Pacific region expected to drive the market revenue growth significantly in the aforesaid region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Diabetic Macular Edema Treatment Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

  1. Executive Summary
  2. Global Diabetic Macular Edema Treatment Market Introduction
    • Global Diabetic Macular Edema Treatment Market – Taxonomy
    • Global Diabetic Macular Edema Treatment Market –Definitions
      • Indication Type
      • Treatment
      • End User
  1. Global Diabetic Macular Edema Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Diabetic Macular Edema Treatment Market Dynamic Factors – Impact Analysis
    • Global Diabetic Macular Edema Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Diabetic Macular Edema Treatment Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Diabetic Macular Edema Treatment Market, By Indication Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Diffuse Diabetic Macular Edema
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Focal Diabetic Macular Edema
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Diabetic Macular Edema Treatment Market Forecast, By Treatment,2015 – 2019 and Forecast, 2020 – 2026
    • Laser Treatment
      • Scatter Laser
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Grid pattern photocoagulation
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Focal Laser
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Intravitreal Steroids
        • Ozurdex
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Lluvien
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Kenalog
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Anti-angiogenic Drugs Injection
          • Eylea
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Avastin
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Lucentis
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Others
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
  1. Global Diabetic Macular Edema Treatment Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ophthalmic Clinics
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Surgical Centers
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Diabetic Macular Edema Treatment Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Region, 2020 – 2026
  2. North America Diabetic Macular Edema Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Indication Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2020 – 2026
    • North America Diabetic Macular Edema Treatment Market Dynamics – Trends
  3. Europe Diabetic Macular Edema Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Indication Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2020 – 2026
    • Europe Diabetic Macular Edema Treatment Market Dynamics – Trends
  4. Asia-Pacific Diabetic Macular Edema Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Indication Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2020 – 2026
    • Asia-Pacific Diabetic Macular Edema Treatment Market Dynamics – Trends
  5. Latin America Diabetic Macular Edema Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Indication Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2020 – 2026
    • Latin America Diabetic Macular Edema Treatment Market Dynamics – Trends
  6. Middle East and Africa Diabetic Macular Edema Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Indication Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Diffuse Diabetic Macular Edema
      • Focal Diabetic Macular Edema
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laser Treatment
        • Scatter Laser
        • Grid pattern photocoagulation
        • Focal Laser
      • Intravitreal Steroids
        • Ozurdex
        • Lluvien
        • Kenalog
      • Anti-angiogenic Drugs Injection
        • Eylea
        • Avastin
        • Lucentis
      • Anti–vascular Endothelial Growth Factor (VEGF) Therapy
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ophthalmic Clinics
      • Ambulatory Surgical Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Diabetic Macular Edema Treatment Market – Opportunity Analysis Index, By Indication Type, By Treatment, By End User, and Country, 2020 – 2026
    • MEA Diabetic Macular Edema Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Indication Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Eyetech Pharmaceuticals (U.S)
      • Alimera Sciences (U.S)
      • Archemix (U.S)
      • Genentech Inc. (U.S)
      • Novartis Europharm Limited (Novartis AG) (India)
      • Stiefel Laboratories Inc., (GlaxoSmithKline Plc.) (U.S)
      • Allergan, Inc. (Ireland)
      • IRIDEX Corporation (U.S)
      • Bausch and Lomb Incorporated (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • Eyetech Pharmaceuticals (U.S)
  • Alimera Sciences (U.S)
  • Archemix (U.S)
  • Genentech Inc. (U.S)
  • Novartis Europharm Limited (Novartis AG) (India)
  • Stiefel Laboratories Inc., (GlaxoSmithKline Plc.) (U.S)
  • Allergan, Inc. (Ireland)
  • IRIDEX Corporation (U.S)
  • Bausch and Lomb Incorporated (U.S)

Description

The global Diabetic Macular Edema Treatment Market is projected to grow at a CAGR of 3.5% during the forecast period 2021 to 2027. Diabetic macular edema is a leading cause of vision impairment among people. Macular edema occurs when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling leading to distorted vision. Diabetic macular edema is a disease that is followed by diabetic retinopathy. Diabetic retinopathy is the condition which severely damages the blood vessels of the retina, resulting in vision defects or vision loss. These blood vessels, if left untreated, due to pressure in the eye results in fluid leakage, causing Diabetic Macular Edema (DME). Increase in the prevalence of diabetes is the major factor driving growth of global market. The prevalence of diabetic macular edema is found to be higher in type 2 diabetes patients than in type 1 diabetes patients. In the projected period of 2020-2027, new and creative research and development for the treatment of diabetic macular edoema would likely increase the growth of the diabetic macular edema treatment market. On the other hand, advancements in ophthalmic surgery techniques and pharmaceutical firms’ R&D investments would enhance numerous opportunities, resulting in the diabetic macular edoema treatment market growing over the projection period. During the projected period, the diabetic macular edoema treatment market is expected to be hampered by high medical costs for patients and frequent visits to physicians. There is no need for treatment in the early stages of DME unless the patients are able to keep their blood sugar levels under control. Laser photocoagulation is the standard treatment for diabetic macular edoema if the condition becomes severe. This method involves administering a pattern of burns or cauterising leaky blood vessels using a laser to minimise edoema. Retinal experts use anti-vascular endothelial growth factorcorticosteroids injections in combination with laser photocoagulation to avoid the treatment’s negative effects. Only two approved medications for treating DME are now available on the market: Lucentis and Ozurdex. Clinical trials are now underway for other therapy options.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX